Doctor profile · Federal record
Dr. Praveen Tumula, M.D
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Amarillo, TX
- NPI 1447402896
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1826 Point West Pkwy
Amarillo, TX 791242167
(806) 358-8654
fax (806) 356-8687 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- October 2008 — 18 yrs on file
- Profile last updated
- July 15, 2024
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #P0509
- Medicaid
- TX #385163602
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447402896. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
264,114
Distinct HCPCS
10
Medicare allowed
$2,793,901
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 72,750 | 70 | $1 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 34,680 | 43 | $0 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 33,600 | 25 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,020 | 35 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,200 | 28 | $54 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12,801 | 110 | $0 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 12,480 | 17 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,700 | 15 | $47 | |
J9267 |
Injection, paclitaxel, 1 mg | 10,331 | 25 | $0 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 7,000 | 11 | $13 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 2,834. This provider delivers 93× the peer median.Open Payments
Industry payments received
All-time total
$2,680
Transactions
6
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $2,520.00 | |
| Celgene Corporation | 1 | $65.34 | |
| Abbott Laboratories | 1 | $47.65 | |
| AstraZeneca Pharmaceuticals LP | 1 | $25.23 | |
| Medtronic, Inc. | 1 | $21.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,718
Patients
396
Total drug cost
$5,488,461
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 179 | 40 | $6,588 |
| Acyclovir | Generic | 176 | 46 | $4,409 |
| Revlimid (Lenalidomide) | Brand | 150 | 23 | $2,333,128 |
| Allopurinol | Generic | 149 | 31 | $2,444 |
| Eliquis (Apixaban) | Brand | 134 | 23 | $109,462 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 127 | 42 | $5,880 |
| Potassium Chloride | Generic | 126 | 43 | $1,700 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 111 | 14 | $1,811,785 |
| Xarelto (Rivaroxaban) | Brand | 110 | 23 | $106,525 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 108 | 23 | $7,180 |
Frequently asked questions
What is Dr. Praveen Tumula's medical specialty?
Dr. Praveen Tumula practices Hematology & Oncology Physician in Amarillo, TX.
Where does Dr. Praveen Tumula practice?
Dr. Praveen Tumula practices at 1826 Point West Pkwy, Amarillo, TX 791242167. Office phone: 8063588654.
What is Dr. Praveen Tumula's NPI?
Dr. Praveen Tumula's National Provider Identifier (NPI) is 1447402896, issued by NPPES.
Does Dr. Praveen Tumula accept Medicare assignment?
Yes. Dr. Praveen Tumula accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Praveen Tumula commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.